Jayr Schmidt Filho

Hematologist - blood malignancies, cell therapy and hematopoietic stem cell transplant, Head of hematology department at A.C.Camargo Cancer Center

[Jayr Schmidt Filho @JayrSF_]

Sundar Jagannath from @MountSinaiNYC brought a compelling perspective to Brazilian hematologists during a very emotional plenary session at the Brazilian Hematology Conference #HEMO2026: cure in myeloma as a tangible possibility. Sustained MRD negativity and advances in immunotherapy are giving this goal an increasingly concrete foundation. #CureMyeloma

[Jayr Schmidt Filho @JayrSF_]

@thiagoxcarneiro This our HEMO! 🇧🇷🩸🧬

[Thiago Carneiro @thiagoxcarneiro]

Guess what happens in the largest Hematology meeting of the Americas after ASH. Tip: Brazil+Rio.
#HEMO2026

[Jayr Schmidt Filho @JayrSF_]

Proud to share our latest publication in Neurological Sciences, highlighting the collaborative translational research efforts of our multidisciplinary team at A.C.Camargo Cancer Center.

In a patient with multiple myeloma, we combined SARS-CoV-2 detection in cerebrospinal fluid with advanced proteomic profiling, identifying 184 differentially expressed proteins and uncovering pathways associated with neuroinflammation, blood–brain barrier dysfunction, and potential neurodegenerative mechanisms.

@marjorierunning

🔗 https://t.co/c61xY4mqWb

#MultipleMyeloma #TranslationalResearch #Neuroinflammation

[Ankit kansagra @kansagraMD]

33 patients started teclistamab or talquetamab step-up dosing fully outpatient, with prophylactic tocilizumab.

CRS: 0.

Real-world poster from Mount Sinai at #IMS26, and the most useful part for community programs isn't the CRS rate. It's the eligibility list.

[NEJM @NEJM]

Science behind the Study: Anito-cel for Multiple Myeloma https://t.co/oNdvXQB5Ip

#Hematology #Genetics

[Binod Dhakal @bhemato]

Phase I results of Anito-cel and d-domain story published in NEJM! Exciting results and very delighted to be a part of this study @MedicalCollege @MCWCancerC2u8v

[Hemostasis Today @HemostasisToday]

Real-World Brazilian Data Reveal Inequalities in MDS Care - Jayr Schmidt Filho (@jayrsf_ )

https://t.co/PSl4O5qzaq

#HemostasisToday

[ScienceLink @sciencelinkonco]

#HematoTime
Dr. Jayr Schmidt Filho (@jayrsf_)

https://t.co/Snr2jxQV1N

[Americas Health Foundation (AHF) @AmeriHealthFoun]

Advanced therapies like CAR T-cell treatment require coordination across clinicians, regulators, patient advocates, and health system stakeholders.

Our new paper in Frontiers in Hematology explores the challenges and opportunities for equitable CAR T-cell therapy access +

[Blood Journals Portfolio @BloodPortfolio]

Tailored infectious screening, including endemic pathogens, is critical in CAR-T candidates in endemic areas. Read in Blood Global Hematology: https://t.co/CXAE12d9iK #CARTCell #BloodGlobal

[SBTMO @SBTMO]

O Dr. Jayr Schmidt Filho (A.C.Camargo Cancer center), um dos palestrantes do V Multirregional SBTMO 2026, convida a todos para participarem do nosso Encontro de Prevenção e Tratamento de Recaídas pós TCTH, que ocorrerá na próxima semana, dia 13 de março! https://t.co/P8EMVWEUd9

[Jayr Schmidt Filho @JayrSF_]

@hhashmi87 @bhemato @Merida Glad to share this moment with you all!

[Hamza Hashmi @hhashmi87]

Great day sharing ideas, research, and debates on #myeloma with @bhemato and colleagues at MMSparks event in @merida #CureMyeloma #mmsm #MedEd #medtwitter #CART #bispecifics #MyelomaMexico #MyelomaFriends

[Luciano J Costa @End_myeloma]

Newly diagnosed with MM? MASTER-2 addressed response adapted therapy with the perspective of finite treatment. Accruing fast! #mmsm

[Jayr Schmidt Filho @JayrSF_]

Great session at Brazilian Lymphoma Conference (BLC) 2025 from @abhhoficial: traditional debate on CART vs Bispecifics, with @GuiperiniMD, and moderated by Daniel Tabak and Belinda Simoes. The panel's overall opinion is that both therapies are complementary and not antagonistic.

[Lymphoma Experience @LymphomaEx]

Necesitamos empujar el desarrollo y acceso de CAR-T en Latinoamérica.

Seguiremos empujando para avanzar.

#LEx25

[Jayr Schmidt Filho @JayrSF_]

@LymphomaEx Our pleasure!

[Jayr Schmidt Filho @JayrSF_]

Honored to participate in Lymphoma Experience (LEx), organized by @cytohance @iHematologo and @nico30f in Puerto Varas 🇨🇱
Pleasure to discuss the reality of CAR-T cell treatment in LATAM, sharing our experience through clinical cases presented by @ThaisFischer4 🩸🧬

[Jayr Schmidt Filho @JayrSF_]

@LymphClinician Glad to have you with us!